American Society of Interventional Pain Physicians | September 5, 2018
6.75 A MA PRA Category 1 Credits™
11 AMA PRA Category 1 Credits

Neuromodulation Cadaver Workshop will be
limited to 4 physicians per station.
Minimum attendance of 4 physicians required thirty days prior to meeting or
course and workshop is subject to cancellation. Register early!

1 Day Review Course and 1.5 Day Cadaver Workshop.
1. Trial lead placement for low back pain
2. Trial lead placement for neck pain
3. Spinal cord stimulator permanent implant placement (conventional)
4. Wireless trial and permanent placement
5. Transforaminal trial and permanent placement
6. Placement of intrathecal infusion system
7. Intercostal nerve stimulation
8. Sacroiliac stimulation
9. Suprascapular nerve stimulation
10. Free forum

Procedures are subject to change.

18 A MA PRA Category 1 Credits™

6.75 A MA PRA Category 1 Credits™

11 AMA PRA Category 1 Credits

7 AMA PRA Category 1 Credits™
(Plus Free Online Lectures)
11 AMA PRA Category 1 Credits™
Studies Warn of Pregabalin Deaths

Two new studies – one in Canada and one in Australia – should give pause to patients who use opioids and pregabalin (Lyrica), an anticonvulsant medication increasingly prescribed for fibromyalgia, neuropathy and other chronic pain conditions. Both studies found a number of overdose deaths that involve – but were not necessarily caused -- by pregabalin.
The Canadian study, published in the Annals of Internal Medicine , looked at over 1,400 patients in Ontario on opioid medication from 1997 to 2016 who died from opioid-related causes. Another group of over 5,000 surviving opioid patients was used as a control group.
Researchers found that patients who were co-prescribed opioids and pregabalin had a significantly higher risk of an overdose.
The risk of death was over two times higher for patients receiving opioids and a high dose of pregabalin (over 300mg) compared to those who took opioids alone.

'Death Certificate Project' Terrifies California Doctors
Hundreds threatened with disciplinary action for opioid scripts to patients who overdosed

Brian Lenzkes, MD, got a letter last December from the Medical Board of California that left him shocked and scared.
The licensing agency told him it had received a "complaint filed against you" regarding a patient who died of a prescription overdose in May 2013 -- four and a half years earlier.
In stern bold type, the letter's second paragraph said the man "died from an overdose of hydrocodone, oxycodone, and zolpidem." The state's prescription drug database,  CURES  (California Controlled Substance Utilization Review and Evaluation System), showed that "Dr. Brian J. Lenzkes had been prescribing long-term excessive amounts of these, including benzos," and that "it is unknown what conditions the patient suffered from which required such medication."

Interventional Pain Management Reports is an Open Access online journal, a peer-reviews journal dedicated to the publication of case reports, brief commentaries and reviews and letters to the editor. It is a peer-reviewed journal written by and directed to an audience of interventional pain physicians, clinicians and basic scientists with an interest in interventional pain management and pain medicine. 

Interventional Pain Management Reports is an official publication of the American Society of Interventional Pain Physicians (ASIPP) and is a sister publication of Pain Physician . Interventional Pain Management Reports Interventional Pain Management Reports is an open access journal, available online with free full manuscripts.  

The benefits of publishing in an open access journal that has a corresponding
print edition journal are:  
  • Your article will have the potential to obtain more citations.
  • Your article will be peer-reviewed and published faster than other journals.
  • Your article can be read by a potentially much larger audience compared with traditional subscription-only journals.  
  • Open Access journals are FREE to view, download and to print.

So submit today your:
  • Case Reports
  • Technical Reports
  • Editorials
  • Short Perspectives

National Provider Identifiers Are Vulnerable to Theft

HealthDay News — National Provider Identifiers (NPIs) are vulnerable to identity theft, according to an article published in  Physicians Practice .
Thousands of health care providers' NPIs are stolen each year and are used for further fraudulent schemes, including Medicaid and Medicare fraud. NPIs are vulnerable because they are not confidential and are publicly available on the National Plan and Provider Enumeration System. In addition, NPIs in  electronic health records  are accessible by rogue employees and  possible cyberattacks.
To prevent NPI theft and resulting health care fraud, there are steps providers can take. These include sharing NPIs sparingly and knowing who is using the NPI and why. Providers can monitor claims and reimbursements to verify that billed services match actual income and that reimbursements are not being diverted elsewhere. They also can monitor enrollment information and report any changes, such as practice location. 

Pain Physician
July/August 2018 Issue Features

Health Policy Review
  • Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic
Systematic Reviews
  • Is Unilateral Percutaneous Kyphoplasty Superior to Bilateral Percutaneous Kyphoplasty for Osteoporotic Vertebral Compression Fractures? Evidence from a Systematic Review of Discordant Meta-Analyses
  • Prevalence of Recurrent Herniation Following Percutaneous Endoscopic Lumbar Discectomy: A Meta-Analysi
Randomized Trials
  • Thermal Versus Super Voltage Pulsed Radiofrequency of Stellate Ganglion in Post-Mastectomy Neuropathic Pain Syndrome: A Prospective Randomized Trial
  • Evaluation of an Experimental Pain Model by Noncompartmental Analysis of Results from a Randomized Placebo Controlled Trial
  • Transforaminal vs Interlaminar Epidural Steroid Injection for Acute-Phase Shingles: A Randomized, Prospective Trial

HCA Healthcare to Buy Nonprofit Mission Health in North Carolina
HCA will pay about $1.5 billion and will get seven of Mission’s locations
Health-care services company  HCA Healthcare   HCA -0.58%  has agreed to buy Mission Health, a nonprofit health system in North Carolina, for about $1.5 billion.
HCA will be buying Mission’s seven locations, primarily hospitals. Mission said the North Carolina attorney general will receive the agreement to review the deal.
Mission’s board said in March that it agreed “to enter into exclusive discussions” with HCA.

Access to this article may be limited.

Doctor Burnout Likely to Impair Care

WEDNESDAY, Sept. 5, 2018 (HealthDay News) -- You're much more likely to receive poor or unprofessional health care if your doctor suffers from burnout, a new analysis contends.
Physicians who feel burned out are twice as likely to make a mistake that endangers patient safety or to behave in an unprofessional manner, according to the review.
It's even worse for young doctors. They're more than three times as likely to behave unprofessionally as a result of burnout, the researchers found.

State Society News 

July 12-14, 2019
GSIPP 2019 - 15th Annual Meeting & Pain Summit
The Cloister Hotel at Sea Island
Sea Island, GA
For more information, contact Karrie Kirwan at or Tara Morrison at or 770-613-0932.

Send in your state society meeting news to Holly Long,
ASIPP | Pain Physician Journal | Phone | Fax | Email